×

Australia’s Mayne Pharma jumps to 1-year high on $408 million Gedeon Richter takeover

By Thomson Reuters Nov 16, 2026 | 6:03 PM

Nov 17 (Reuters) – Mayne Pharma said on Tuesday that Hungarian drugmaker Gedeon Richter had agreed to buy the Australian firm for an equity value of about A$604 million ($407.76 million), ​sending its shares soaring 86% to a one-year high.

The deal ‌put the stock on track for its best session on record, if the current gains hold, with shares last trading at A$5.97.

Gedeon Richter has offered A$6.40 per Mayne share, a 99.4% premium to the stock’s last close on Monday.

“The ‌board ​has carefully considered the proposal from Richter ⁠and has unanimously concluded that ⁠it is in the best interests of Mayne Pharma shareholders, in the absence of a Superior Proposal and subject to the independent expert’s conclusion,” said Mayne Pharma Chair Bruce Robinson.

The scheme is ​subject to certain regulatory approvals, among other conditions, including completion of the sale of its International business segment to Evaris Pharma.

“Mayne’s ⁠existing portfolio – including our estetrol-based innovative combination ⁠contraceptive pill – and its commercial footprint provide a ​strong base to build on and will allow us to bring new ​treatments to millions of women in the United States across ‌several therapeutic segments, where there is significant unmet medical need,” Richter Deputy CEO László Kovács said.

The deal follows a nearly two-year saga between US-based Cosette Pharmaceuticals and Mayne, during which the former sought to ⁠walk away from its A$672 million offer, citing a “material adverse change” in the Australian drugmaker’s business and finances.

Australia had blocked the deal last year ⁠on national interest ‌grounds after Cosette threatened to shut Mayne’s Adelaide ⁠manufacturing plant, which employs about 200 people and is ​one ‌of the company’s two main factories.

Mayne makes branded ​and generic ⁠drugs focused on women’s health, dermatology and infectious diseases.

Cosette’s offer valued Mayne shares at A$7.40 apiece. As of Monday’s close, the stock had lost more than half its value since the offer was first announced.

($1 = 1.4813 Australian dollars)

(Reporting by Sneha Kumar in Bengaluru; Editing by Sahal Muhammed ​and Sherry Jacob-Phillips)